Rather than reducing the total weekly amount, which would diminish therapeutic benefit, the provider splits the existing dose into two injections
This medication is also used off-label for lowering body weight in obese (body mass index 30 or more) and overweight (BMI 27 or more) individuals
Dosing accuracy matters , and doubling up is far more dangerous than an intramuscular injection
Lean Mass Body Composition Analysis: Measuring Body Water, Fat, and Muscle GLP-1 Impact: Cardiovascular Disease and Disease Control The Sarcopenia Risk: Why Muscle Quality Matters Preservation Protocol: Nutrition and Mechanical Load Closing Thoughts Semaglutide, marketed under trade names such as Ozempic and Wegovy, functions as a glucagon-like peptide-1 (GLP-1) receptor agonist
Your Next Steps You now have a complete, actionable 7-day meal plan designed specifically for GLP-1 users
Some clinical studies have found that a small number of people taking Ozempic (semaglutide) experience worsening of their diabetic retinopathy
